Concetta Saponaro Selected Research

Neoplasms (Cancer)

5/2022	Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes.
1/2022	The Biological Relevance of NHERF1 Protein in Gynecological Tumors.
11/2021	PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study.
1/2021	Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients.
2/2020	Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients.
1/2020	NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.
4/2018	NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.
5/2017	3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.
6/2015	Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer.
2/2014	Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Concetta Saponaro Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 11/2011
9	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2011
4	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 09/2012
4	Triple Negative Breast Neoplasms 05/2022 - 09/2019
3	Carcinogenesis 01/2022 - 09/2012
3	Inflammation (Inflammations) 04/2018 - 01/2010
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 11/2021 - 04/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2017 - 01/2017
2	Hypoxia (Hypoxemia) 01/2013 - 11/2011
1	Obesity 02/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022
1	Warts (Wart) 11/2022
1	Condylomata Acuminata (Genital Wart) 11/2022
1	Adenoma (Adenomas) 01/2018
1	Blast Crisis (Blast Phase) 05/2017
1	Leukemia 01/2017
1	Hemangiosarcoma (Angiosarcoma) 02/2014
1	Familial Breast Cancer 01/2013
1	Cysts 04/2011
1	Neuroinflammatory Diseases 01/2011
1	Rheumatic Diseases (Rheumatism) 10/2007

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
4	sodium-hydrogen exchanger regulatory factorIBA 01/2022 - 11/2011
3	InflammasomesIBA 05/2022 - 01/2020
3	CytokinesIBA 01/2021 - 01/2011
3	CateninsIBA 07/2019 - 01/2014
2	Phenobarbital (Luminal)FDA Link 05/2022 - 09/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 01/2013
2	Hormones (Hormone)IBA 01/2013 - 03/2012
2	LipopolysaccharidesIBA 03/2011 - 01/2010
1	Tryptophan (L-Tryptophan)FDA Link 02/2024
1	pterostilbeneIBA 02/2024
1	ResveratrolIBA 02/2024
1	Amino Acids FDA Link 02/2024
1	AntioxidantsIBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	nirogacestatIBA 01/2022
1	NLR ProteinsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 09/2019
1	Colchicine FDA LinkGeneric 05/2017
1	TubulinIBA 05/2017
1	Imatinib Mesylate (Gleevec)FDA Link 05/2017
1	Glycogen Synthase KinasesIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Sodium-Hydrogen ExchangersIBA 06/2015
1	Bevacizumab (Avastin)FDA Link 02/2014
1	vandetanib (ZD6474)IBA 02/2014
1	Angiogenesis InhibitorsIBA 02/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2014
1	Tryptases (Tryptase)IBA 08/2013
1	PAR-2 ReceptorIBA 08/2013
1	Peptide Hydrolases (Proteases)FDA Link 08/2013
1	Tumor Biomarkers (Tumor Markers)IBA 03/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2011
1	Estrogen ReceptorsIBA 11/2011
1	human ERBB2 proteinIBA 11/2011
1	Polygalacturonase (Pectinase)IBA 04/2011
1	Complementary DNA (cDNA)IBA 04/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2011
1	RibonucleoproteinsIBA 10/2007
1	AutoantibodiesIBA 10/2007

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2014
1	Immunomodulation 11/2021
1	Immunotherapy 02/2020
1	Precision Medicine 04/2018